Reviewers for the Journal, July–December 2023 | NEJM
Editorial from The New England Journal of Medicine — Reviewers for the Journal, July–December 2023
Editorial from The New England Journal of Medicine — Reviewers for the Journal, July–December 2023
In patients with immune thrombotic thrombocytopenic purpura (iTTP), autoantibodies against the metalloprotease ADAMTS13 lead to catastrophic microvascular thrombosis. However, the potential benefit…
Nature Immunology – Cancer and aging are associated with each other, but underlying mechanisms contributing to this correlation are unclear. Here the authors identify a…
In this narrative medicine essay, a pediatric oncologist grapples with the emotions of loss and guilt while attending the memorial service of her 8-year-old patient.
#cancer #groundshot #moonshot #commonsenseoncology
Speakers at the ESTRO 2024 meeting discussed the potential for upright treatment to increase global access to radiotherapy, particularly particle therapy
The king, who was diagnosed with cancer in February but has since returned to public duties, unveiled the striking painting by Jonathan Yeo at Buckingham…
Combination chemotherapy with or without radiation has served as the primary therapeutic option for classic Hodgkin lymphoma (cHL), leading to durable remission in a majority…
Low-grade gliomas present a formidable challenge in neuro-oncology because of the challenges imposed by the blood-brain barrier, predilection for the young adult population, and propensity…
The goal of the report is to increase public understanding of cancer health disparities and of the importance of research on disparities to save lives.
The goal of the report is to increase public understanding of cancer health disparities and of the importance of research on disparities to save lives.